BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11060299)

  • 1. Threonine 180 is required for G-protein-coupled receptor kinase 3- and beta-arrestin 2-mediated desensitization of the mu-opioid receptor in Xenopus oocytes.
    Celver JP; Lowe J; Kovoor A; Gurevich VV; Chavkin C
    J Biol Chem; 2001 Feb; 276(7):4894-900. PubMed ID: 11060299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu and delta opioid receptors are differentially desensitized by the coexpression of beta-adrenergic receptor kinase 2 and beta-arrestin 2 in xenopus oocytes.
    Kovoor A; Nappey V; Kieffer BL; Chavkin C
    J Biol Chem; 1997 Oct; 272(44):27605-11. PubMed ID: 9346897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mu-Opioid receptors desensitize less rapidly than delta-opioid receptors due to less efficient activation of arrestin.
    Lowe JD; Celver JP; Gurevich VV; Chavkin C
    J Biol Chem; 2002 May; 277(18):15729-35. PubMed ID: 11861651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy.
    Kovoor A; Celver JP; Wu A; Chavkin C
    Mol Pharmacol; 1998 Oct; 54(4):704-11. PubMed ID: 9765514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin.
    Appleyard SM; Celver J; Pineda V; Kovoor A; Wayman GA; Chavkin C
    J Biol Chem; 1999 Aug; 274(34):23802-7. PubMed ID: 10446141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation of the mu-opioid receptor regulates agonist intrinsic efficacy.
    McLaughlin JP; Chavkin C
    Mol Pharmacol; 2001 Jun; 59(6):1360-8. PubMed ID: 11353794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct domains of the mu-opioid receptor control uncoupling and internalization.
    Celver J; Xu M; Jin W; Lowe J; Chavkin C
    Mol Pharmacol; 2004 Mar; 65(3):528-37. PubMed ID: 14978231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization.
    Miess E; Gondin AB; Yousuf A; Steinborn R; Mösslein N; Yang Y; Göldner M; Ruland JG; Bünemann M; Krasel C; Christie MJ; Halls ML; Schulz S; Canals M
    Sci Signal; 2018 Jul; 11(539):. PubMed ID: 30018083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus.
    Li AH; Wang HL
    J Neurochem; 2001 Apr; 77(2):435-44. PubMed ID: 11299306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization.
    Jin W; Brown S; Roche JP; Hsieh C; Celver JP; Kovoor A; Chavkin C; Mackie K
    J Neurosci; 1999 May; 19(10):3773-80. PubMed ID: 10234009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-induced, G protein-dependent and -independent down-regulation of the mu opioid receptor. The receptor is a direct substrate for protein-tyrosine kinase.
    Pak Y; O'Dowd BF; Wang JB; George SR
    J Biol Chem; 1999 Sep; 274(39):27610-6. PubMed ID: 10488100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrestin-dependent but G-protein coupled receptor kinase-independent uncoupling of D2-dopamine receptors.
    Celver J; Sharma M; Thanawala V; Christopher Octeau J; Kovoor A
    J Neurochem; 2013 Oct; 127(1):57-65. PubMed ID: 23815307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct forms of desensitization of G-protein coupled inwardly rectifying potassium currents evoked by alkaloid and peptide mu-opioid receptor agonists.
    Blanchet C; Sollini M; Lüscher C
    Mol Cell Neurosci; 2003 Oct; 24(2):517-23. PubMed ID: 14572471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged stimulation of μ-opioid receptors produces β-arrestin-2-mediated heterologous desensitization of α(2)-adrenoceptor function in locus ceruleus neurons.
    Dang VC; Chieng BC; Christie MJ
    Mol Pharmacol; 2012 Sep; 82(3):473-80. PubMed ID: 22689562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
    Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G
    Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization.
    El Kouhen R; Burd AL; Erickson-Herbrandson LJ; Chang CY; Law PY; Loh HH
    J Biol Chem; 2001 Apr; 276(16):12774-80. PubMed ID: 11278523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation.
    Vaughan DJ; Millman EE; Godines V; Friedman J; Tran TM; Dai W; Knoll BJ; Clark RB; Moore RH
    J Biol Chem; 2006 Mar; 281(11):7684-92. PubMed ID: 16407241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absence of endogenous beta-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation.
    Petraschka M; Li S; Gilbert TL; Westenbroek RE; Bruchas MR; Schreiber S; Lowe J; Low MJ; Pintar JE; Chavkin C
    Neuroscience; 2007 Jun; 146(4):1795-807. PubMed ID: 17467916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A G protein-coupled receptor kinase induces Xenopus oocyte maturation.
    Wang J; Liu XJ
    J Biol Chem; 2003 May; 278(18):15809-14. PubMed ID: 12600992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and Internalization.
    Lowe JD; Sanderson HS; Cooke AE; Ostovar M; Tsisanova E; Withey SL; Chavkin C; Husbands SM; Kelly E; Henderson G; Bailey CP
    Mol Pharmacol; 2015 Aug; 88(2):347-56. PubMed ID: 26013542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.